SEC Form 4 · accession 0001185185-17-002559
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard K Prins
Director
Period of report
Dec 4, 2017
Accepted (ET)
Dec 5, 2017 · 6:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2017 | G | 2,000 | $0.00 | D | 497,000 | D | |
| Common Stock | May 19, 2017 | G | 2,000 | $0.00 | D | 495,000 | D | |
| Common Stock | May 26, 2017 | G | 2,000 | $0.00 | D | 493,000 | D | |
| Common Stock | Jun 2, 2017 | G | 2,000 | $0.00 | D | 491,000 | D | |
| Common Stock | Jun 9, 2017 | G | 2,000 | $0.00 | D | 489,000 | D | |
| Common Stock | Jun 16, 2017 | G | 2,000 | $0.00 | D | 487,000 | D | |
| Common Stock | Jun 23, 2017 | G | 2,000 | $0.00 | D | 485,000 | D | |
| Common Stock | Jun 30, 2017 | G | 2,000 | $0.00 | D | 483,000 | D | |
| Common Stock | Jul 7, 2017 | G | 2,000 | $0.00 | D | 481,000 | D | |
| Common Stock | Jul 14, 2017 | G | 2,000 | $0.00 | D | 479,000 | D | |
| Common Stock | Jul 21, 2017 | G | 2,000 | $0.00 | D | 477,000 | D | |
| Common Stock | Jul 28, 2017 | G | 2,000 | $0.00 | D | 475,000 | D | |
| Common Stock | Aug 4, 2017 | G | 2,000 | $0.00 | D | 473,000 | D | |
| Common Stock | Aug 11, 2017 | G | 2,000 | $0.00 | D | 471,000 | D | |
| Common Stock | Aug 18, 2017 | G | 2,000 | $0.00 | D | 469,000 | D | |
| Common Stock | Aug 25, 2017 | G | 2,000 | $0.00 | D | 467,000 | D | |
| Common Stock | Sep 1, 2017 | G | 2,000 | $0.00 | D | 465,000 | D | |
| Common Stock | Sep 8, 2017 | G | 2,000 | $0.00 | D | 463,000 | D | |
| Common Stock | Sep 15, 2017 | G | 2,000 | $0.00 | D | 461,000 | D | |
| Common Stock | Sep 22, 2017 | G | 2,000 | $0.00 | D | 459,000 | D | |
| Common Stock | Sep 29, 2017 | G | 2,000 | $0.00 | D | 457,000 | D | |
| Common Stock | Oct 6, 2017 | G | 2,000 | $0.00 | D | 455,000 | D | |
| Common Stock | Oct 13, 2017 | G | 2,000 | $0.00 | D | 453,000 | D | |
| Common Stock | Oct 20, 2017 | G | 2,000 | $0.00 | D | 451,000 | D | |
| Common Stock | Oct 27, 2017 | G | 2,000 | $0.00 | D | 449,000 | D | |
| Common Stock | Nov 3, 2017 | G | 2,000 | $0.00 | D | 447,000 | D | |
| Common Stock | Nov 10, 2017 | G | 2,000 | $0.00 | D | 445,000 | D | |
| Common Stock | Nov 17, 2017 | G | 2,000 | $0.00 | D | 443,000 | D | |
| Common Stock | Nov 24, 2017 | G | 2,000 | $0.00 | D | 441,000 | D | |
| Common Stock | Dec 1, 2017 | G | 2,000 | $0.00 | D | 439,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
THIS FORM 4 IS CONTINUED ON THE FORM 4 FILED IMMEDIATELY AFTER THIS FORM 4. THE FILINGS WERE SEPARATED DUE TO INSUFFICIENT ROOM ON THE FIRST FILING TO SUPPLY ALL OF THE DATA.